Provided by Tiger Trade Technology Pte. Ltd.

Milestone Pharmaceuticals Inc.

1.04
-0.1100-9.57%
Post-market: 1.040.00000.00%19:51 EDT
Volume:2.94M
Turnover:3.18M
Market Cap:122.72M
PE:-1.38
High:1.15
Open:1.15
Low:1.03
Close:1.15
52wk High:3.06
52wk Low:0.6254
Shares:118.00M
Float Shares:67.59M
Volume Ratio:0.85
T/O Rate:4.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7517
EPS(LYR):-0.6674
ROE:-229.65%
ROA:-41.08%
PB:2.94
PE(LYR):-1.56

Loading ...

EMA Accepts Milestone Pharmaceuticals' Application for Etripamil Nasal Spray in PSVT

Reuters
·
Jan 06

Milestone Pharmaceuticals Inc - European Approval Decision Expected by Q1 2027

THOMSON REUTERS
·
Jan 06

Milestone Pharmaceuticals Announces Acceptance of Marketing Authorization Application for Etripamil Nasal Spray in Psvt by the European Medicines Agency

THOMSON REUTERS
·
Jan 06

AptarGroup Wins FDA Approval for Bidose Nasal Delivery System in CARDAMYST Treatment

Reuters
·
Dec 18, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Brystol Myers, Nvidia

Reuters
·
Dec 16, 2025

Milestone Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 16, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Vanda Pharma, Tesla, Zillow

Reuters
·
Dec 15, 2025

Milestone Pharmaceuticals Inc : TD Cowen Raises to Buy From Hold

THOMSON REUTERS
·
Dec 15, 2025

Milestone Pharmaceuticals Inc. : H.c. Wainwright Raises Target Price to $8 From $5

THOMSON REUTERS
·
Dec 15, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Micron Technology, Carvana, ServiceNow

Reuters
·
Dec 15, 2025

Shares of Milestone Pharmaceuticals up 34.8% Premarket After FDA Approves Co's Heart Rhythm Nasal Spray

THOMSON REUTERS
·
Dec 15, 2025

Milestone Pharmaceuticals Says US FDA Approves Cardamyst Spray for Supraventricular Tachycardia Episodes

MT Newswires Live
·
Dec 15, 2025

FDA Approves Milestone Pharmaceuticals’ CARDAMYST Nasal Spray for PSVT

Reuters
·
Dec 13, 2025

Milestone Receives FDA Approval of Cardamyst™ (Etripamil) as First and Only Self-Administered Nasal Spray for Adults With Paroxysmal Supraventricular Tachycardia (Psvt)

THOMSON REUTERS
·
Dec 13, 2025

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:41 AM

Reuters
·
Dec 13, 2025

Milestone Pharma Q3 net loss widens on commercial expenses

Reuters
·
Nov 12, 2025

Milestone Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025